{
    "schema": 1,
    "fid": "liraglutide",
    "type": "article",
    "object_id": 416,
    "title": "Liraglutide: Reference Overview and Reconstitution Notes",
    "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
    "url": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide",
    "facts_url": "https://www.preppinpeppers.com/facts/liraglutide",
    "currency": null,
    "tldr": "Liraglutide is an acylated GLP-1 receptor agonist peptide of about 31 amino acids in the metabolic and weight-regulation category. Reconstitution notes.",
    "facts": [
        {
            "id": "liraglutide:title",
            "category": "identity",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "title",
            "value": "Liraglutide: Reference Overview and Reconstitution Notes",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:published",
            "category": "identity",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "published",
            "value": "2026-08-15",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:author",
            "category": "identity",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "author",
            "value": "Preppin' Peppers Editorial Team",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:topics",
            "category": "identity",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "topics",
            "value": "FDA-approved or specific-use, research",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:summary",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "summary",
            "value": "Liraglutide is an acylated GLP-1 receptor agonist peptide of about 31 amino acids in the metabolic and weight-regulation category. Reconstitution notes.",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:section-1",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What it is",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:section-2",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Liraglutide",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:section-3",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What it is",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:section-4",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Research context and categorization",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:section-5",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Status",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:section-6",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Reconstitution notes (general)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:section-7",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Dilution and handling notes (compound-specific)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:section-8",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Handling and storage",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:section-9",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Related reading",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:section-10",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Tools and supplies",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:section-12",
            "category": "content",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What the research community gets wrong about liraglutide handling",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide"
        },
        {
            "id": "liraglutide:product-gansulin-metal-peptide-pen",
            "category": "products",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "references product",
            "value": "Gansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-metal-peptide-pen"
        },
        {
            "id": "liraglutide:product-gansulin-3ml-cartridge",
            "category": "products",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "references product",
            "value": "Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-3ml-cartridge"
        },
        {
            "id": "liraglutide:source-pubchem-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "NCBI PubChem CID 16134956: Liraglutide (C172H265N43O51) - pubchem.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://pubchem.ncbi.nlm.nih.gov/compound/16134956"
        },
        {
            "id": "liraglutide:source-dailymed-nlm-nih-gov",
            "category": "source",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "VICTOZA (liraglutide) injection label , FDA/DailyMed (solution pH ~8.15, phosphate buffer, store 2-8 C, do not freeze) - dailymed.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a9ef4ea-c76a-4d34-a604-27c5b505f5a4"
        },
        {
            "id": "liraglutide:source-pubmed-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Frederiksen et al., Biophys J 2015: Oligomerization of a Glucagon-like Peptide 1 Analog: Bridging Experiment and Simulations - pubmed.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://pubmed.ncbi.nlm.nih.gov/26340816/"
        },
        {
            "id": "liraglutide:source-pmc-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Knudsen and Lau, Front Endocrinol (Lausanne) 2019: The Discovery and Development of Liraglutide and Semaglutide - pmc.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6474072/"
        },
        {
            "id": "liraglutide:source-pmc-ncbi-nlm-nih-gov-2",
            "category": "source",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Tobaiqy and Elkout, Int J Clin Pharm 2024: Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database - pmc.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10960895/"
        },
        {
            "id": "liraglutide:source-pmc-ncbi-nlm-nih-gov-3",
            "category": "source",
            "entity": "Liraglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Anirban et al., Indian J Endocrinol Metab 2018: Liraglutide - Indian Experience - pmc.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/liraglutide)",
            "evidence": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6330852/"
        }
    ],
    "buy": [],
    "faq": [
        {
            "q": "What is the molecular weight and structure of liraglutide?",
            "a": "Liraglutide is a ~31-amino-acid peptide with a molecular weight of approximately 3,751 Da. A palmitoyl fatty-acid tail is attached to its side chain, allowing loose binding to albumin, which slows enzymatic breakdown and extends molecular stability."
        },
        {
            "q": "How is research-grade liraglutide reconstituted?",
            "a": "Research-grade liraglutide arrives as lyophilized (freeze-dried) powder. It is reconstituted by adding bacteriostatic water; the resulting concentration equals milligrams of powder divided by milliliters of water added (mg/mL)."
        },
        {
            "q": "Is liraglutide prohibited by WADA for competitive athletes?",
            "a": "Liraglutide is not currently named as a prohibited substance on the WADA Prohibited List. The list is updated annually and some GLP-1 class compounds appear on the WADA Monitoring Program, so competitors should verify the current list directly."
        }
    ],
    "jsonld": [
        {
            "@context": "https://schema.org",
            "@type": "Article",
            "headline": "Liraglutide: Reference Overview and Reconstitution Notes",
            "url": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide",
            "mainEntityOfPage": "https://www.preppinpeppers.com/blogs/the-lab/liraglutide",
            "datePublished": "2026-08-15",
            "dateModified": "2026-10-16",
            "author": {
                "@type": "Person",
                "name": "Preppin' Peppers Editorial Team"
            },
            "publisher": {
                "@type": "Organization",
                "name": "PreppinPeppers"
            },
            "description": "Liraglutide is an acylated GLP-1 receptor agonist peptide of about 31 amino acids in the metabolic and weight-regulation category. Reconstitution notes."
        },
        {
            "@context": "https://schema.org",
            "@type": "FAQPage",
            "url": "https://www.preppinpeppers.com/facts/liraglutide",
            "mainEntity": [
                {
                    "@type": "Question",
                    "name": "What is the molecular weight and structure of liraglutide?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Liraglutide is a ~31-amino-acid peptide with a molecular weight of approximately 3,751 Da. A palmitoyl fatty-acid tail is attached to its side chain, allowing loose binding to albumin, which slows enzymatic breakdown and extends molecular stability."
                    }
                },
                {
                    "@type": "Question",
                    "name": "How is research-grade liraglutide reconstituted?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Research-grade liraglutide arrives as lyophilized (freeze-dried) powder. It is reconstituted by adding bacteriostatic water; the resulting concentration equals milligrams of powder divided by milliliters of water added (mg/mL)."
                    }
                },
                {
                    "@type": "Question",
                    "name": "Is liraglutide prohibited by WADA for competitive athletes?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Liraglutide is not currently named as a prohibited substance on the WADA Prohibited List. The list is updated annually and some GLP-1 class compounds appear on the WADA Monitoring Program, so competitors should verify the current list directly."
                    }
                }
            ]
        }
    ],
    "dates": {
        "published": "2026-08-15",
        "modified": "2026-10-16"
    }
}